http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108802391-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2018-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108802391-B |
titleOfInvention | A method based on TiO2 mesogen-induced resonance energy transfer electrochemiluminescence and immunosensing method for ovarian cancer markers |
abstract | The invention discloses a method based on TiO2 mesogen - induced resonance energy transfer type electrochemiluminescence and an immunosensing method for ovarian cancer markers. Pyridine and core/shell quantum dots act as energy donor/acceptor pairs. Anatase TiO2 mesogens can not only carry a large amount of ruthenium bipyridines, but also accelerate the generation of excited ruthenium bipyridines to facilitate the resonance energy transfer of core/shell quantum dots; horseradish peroxidase-enriched Envision complexes As an immunosensing platform, it can carry a large number of signal probes, and at the same time catalyze H2O2 to generate reactive oxide species and promote the luminescence of core/shell quantum dots. ECL‑RET immunosensor has the advantages of high sensitivity and low detection limit. It is used for the detection of ovarian cancer markers and lipoprotein receptors stimulated by lipopolysaccharide, and has important value in the diagnosis and monitoring of early ovarian cancer. |
priorityDate | 2018-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.